GlassScriptPhysician profile
Michael T Daines
NPI 1598973992
$9,272.55
in general payments reported to CMS, 2019-2025
11 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,034 · 2020: $210 · 2021: $172 · 2022: $309 · 2023: $683 · 2024: $409 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,562.03 | 2019-2025 | Trabecular Metal, Comprehensive Shoulder System, Rosa |
| Stryker Corporation | $986.85 | 2019-2025 | Mako, Insignia, Triathlon |
| Globus Medical, INC. | $308.80 | 2025 | Excelsius Gps, Stelkast Generic Knee Instruments, Stelkast Generic Hip Instruments |
| Total Joint Orthopedics, INC. | $185.24 | 2023 | |
| Sawtooth Surgical Solutions INC | $65.45 | 2025 | |
| Bioventus LLC | $55.36 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $41.44 | 2019-2020 | |
| Solventum Corporation | $32.18 | 2024 | Prevena |
| Ferring Pharmaceuticals INC. | $12.24 | 2022 | |
| Ethicon US, LLC | $11.76 | 2019 | |
| Endo Pharmaceuticals INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Daines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.